Streetbeat News

Analyst Ratings

NEM

There has been unusual options activity for Newmont (NYSE:NEM) with deep-pocketed investors adopting a bullish approach. The options scanner at Benzinga highlighted 12 extraordinary options activities for Newmont. The sentiment among these investors is divided, with 50% leaning bullish and 50% bearish. The whales have been targeting a price range from $27.5 to $50.0 for Newmont over the last 3 months. The current price of NEM is down -0.37% at $34.65. An analyst from BMO Capital downgraded its rating to Outperform, setting a price target of $58.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:03 pm

TSX:KMP

RBC Capital analyst Pammi Bir maintains an Outperform rating on KILLAM APT REAL ESTATE INVT TR (TSX:KMP) but lowers the price target from C$23.5 to C$23.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:02 pm

ENV

Envestnet (NYSE:ENV) has received 4 analyst ratings in the last quarter, with 1 being bullish and 3 somewhat bullish. The company's average 12-month price target is $64.25, a decrease of 11.68% from the previous average of $72.75.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:00 pm

ANGI

In the last quarter, Angi (NASDAQ:ANGI) has received 3 bullish, 1 somewhat bullish, and 2 indifferent analyst ratings. The average 12-month price target for Angi, according to 6 analysts, is $4.46, a decrease of 17.71% from the previous average price target of $5.42.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:00 pm

RANI

Rani Therapeutics Hldgs (NASDAQ:RANI) has received mostly bullish ratings from analysts in the last quarter, with 5 bullish and 1 somewhat bullish ratings. The average 12-month price target for the stock, according to 6 analysts, is $18.83, representing a 7.38% decrease from the previous average price target of $20.33.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:00 pm

ARRY

Over the past 3 months, 10 analysts have published their opinion on Array Technologies (NASDAQ:ARRY) stock. The company has an average price target of $28.4, a decrease of 4.98% from the previous average price target of $29.89. The ratings range from bullish to indifferent, with the majority being bullish.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:00 pm

THC

Over the past 3 months, 8 analysts have published their opinion on Tenet Healthcare (NYSE:THC) stock. The average price target is $85.12, representing a 6.2% decrease from the previous average price target of $90.75. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:00 pm

COTY

Analysts have provided various ratings for Coty (NYSE:COTY) within the last quarter, with 1 bullish, 2 somewhat bullish, and 10 indifferent. The average 12-month price target for Coty is $12.4, a decrease of 3.8% from the previous average price target of $12.89.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 6:00 pm

TSX:ISV

RBC Capital analyst Paul Treiber has maintained a 'Sector Perform' rating on Info Servs (TSX:ISV) but lowered the price target from C$25 to C$21.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 5:59 pm

TSX:H

RBC Capital analyst Maurice Choy maintains a 'Sector Perform' rating on Hydro One (TSX:H) and raises the price target from C$36 to C$37.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 5:58 pm